Stevens Capital Management LP Exact Sciences Corp Transaction History

Stevens Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$77.66 - $99.74 $957,314 - $1.23 Million	-12,327 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$90.37 - $122.49 $1.11 Million - $1.51 Million	12,327 New	12,327 $1.11 Million
Q2 2019 Jul 31, 2019	SELL	$89.51 - $118.04 $2.09 Million - $2.76 Million	-23,342 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$61.98 - $96.5 $688,473 - $1.07 Million	11,108 Added 90.8%	23,342 $2.02 Million
Q4 2018 Feb 06, 2019	BUY	$56.04 - $82.66 $685,593 - $1.01 Million	12,234 New	12,234 $772,000
Q2 2018 Aug 09, 2018	SELL	$37.84 - $69.96 $1.64 Million - $3.04 Million	-43,422 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$39.82 - $57.53 $37,470 - $54,135	941 Added 2.22%	43,422 $1.75 Million
Q4 2017 Feb 13, 2018	BUY	$46.49 - $60.51 $1.97 Million - $2.57 Million	42,481	42,481 $2.23 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.